International Stem Cell (ISCO, $0.11) was a top loser this month, diving to $0.11 per share. Of the 841 stocks analyzed in the Biotechnology Industry throughout this month, of them (4) exhibited an Uptrend while of them (5) were in a Downtrend. A.I.dvisor found 439 similar cases when ISCO's price dropped within one month. In out of those 439 cases, ISCO's price continued to decline in the subsequent month. Based on this historical data, A.I. thinks the odds of a Downtrend continuation for ISCO are